We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$162M
AUM Growth
-$41.7M
Cap. Flow
-$37.4M
Cap. Flow %
-22.99%
Top 10 Hldgs %
67.12%
Holding
128
New
40
Increased
32
Reduced
13
Closed
25

Top Buys

Rank Stock Value
1
DBX icon
Dropbox
DBX
+$1.92M
2
SNCR
Synchronoss Technologies
SNCR
+$1.8M
3
EGIO
Edgio, Inc. Common Stock
EGIO
+$1.62M
4
SILC icon
Silicom
SILC
+$1.38M
5
CYBE
Cyberoptics Corp
CYBE
+$1.27M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$3.25M
2
ON icon
ON Semiconductor
ON
+$1.95M
3
NTNX icon
Nutanix
NTNX
+$1.56M
4
FLNA
Filana Therapeutics
FLNA
+$1.22M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.2M

Sector Composition

Rank Sector Weight
1 Technology 8.04%
2 Healthcare 6.42%
3 Industrials 2.39%
4 Consumer Discretionary 1%
5 Communication Services 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLI icon
51
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
$272K 0.17%
4,604
+868
+23% +$65.4K
RFIL icon
52
RF Industries
RFIL
$135M
$259K 0.16%
65,372
– –
XPH icon
53
State Street SPDR S&P Pharmaceuticals ETF
XPH
$491M
$237K 0.15%
6,577
+1,066
+19% +$45.4K
FEED
54
ENvue Medical Inc
FEED
$2.09M
$236K 0.15%
50
+42
+525% +$246K
RESN
55
DELISTED
Resonant Inc.
RESN
$219K 0.13%
+148,491
New +$286K
SONM icon
56
DNA X Inc
SONM
$5.73M
$218K 0.13%
173
+38
+28% +$182K
X
57
PUT
DELISTED
US Steel
X
$215K 0.13%
177,900
+31,900
+22% +$267K
BIOL
58
DELISTED
Biolase, Inc.
BIOL
$212K 0.13%
226
+16
+8% +$24.9K
DCOY
59
Decoy Therapeutics
DCOY
$2.31M
$208K 0.13%
+8
New +$487K
ACOR
60
PUT
DELISTED
Acorda Therapeutics
ACOR
$208K 0.13%
+835
New +$164K
MX icon
61
Magnachip Semiconductor
MX
$127M
$201K 0.12%
+18,236
New +$221K
FLNA
62
Filana Therapeutics
FLNA
$49.8M
$200K 0.12%
48,535
-183,907
-79% -$1.22M
DUOT icon
63
Duos Technologies
DUOT
$285M
$164K 0.1%
+34,639
New +$181K
TRUE
64
DELISTED
TrueCar
TRUE
$163K 0.1%
+67,050
New +$227K
SYK icon
65
PUT
Stryker
SYK
$131B
$160K 0.1%
+16,600
New +$3.24M
COOP
66
DELISTED
Mr. Cooper
COOP
$152K 0.09%
+20,750
New +$240K
VIRX
67
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$150K 0.09%
+10,352
New +$225K
APVO icon
68
Aptevo Therapeutics
APVO
$4.92M
– –
0
– –
COOP
69
CALL
DELISTED
Mr. Cooper
COOP
$120K 0.07%
+119,500
New +$1.38M
PDSB icon
70
PDS Biotechnology
PDSB
$40M
$118K 0.07%
+162,000
New +$281K
TVTX icon
71
PUT
Travere Therapeutics
TVTX
$5.11B
$106K 0.07%
71,800
+50,300
+234% +$757K
AVDL
72
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
$103K 0.06%
+58,800
New +$452K
ALNA
73
DELISTED
Allena Pharmaceuticals
ALNA
$99K 0.06%
102,794
-141,392
-58% -$283K
QUMU
74
DELISTED
Qumu Corp.
QUMU
$78K 0.05%
46,896
-86,463
-65% -$176K
ICPT
75
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$76K 0.05%
+30,300
New +$2.72M
1 2
3
4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Worth Venture Partners held 128 positions worth $162M, down 20% from $204M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Worth Venture Partners withdrew a net $37.4M in Q1 2020, closing 25 positions and reducing 13 holdings. Its most notable exit was Teladoc Health, an estimated $3.25M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8% of assets, up from 6.9% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Worth Venture Partners opened a new position in Dropbox worth $1.91M.

  • Worth Venture Partners's largest Q1 2020 buy was Dropbox: 105,750 shares worth $1.91M.
  • Worth Venture Partners added most to Synchronoss Technologies in Q1 2020, an estimated $1.8M increase.
  • Worth Venture Partners's biggest Q1 2020 reduction was Filana Therapeutics, cutting an estimated $1.22M.
  • Worth Venture Partners fully exited Teladoc Health in Q1 2020, selling an estimated $3.25M.
  • Worth Venture Partners's ten largest holdings make up 67% of its $162M portfolio in Q1 2020.
  • Worth Venture Partners opened 40 new positions and closed 25 in Q1 2020.
  • Worth Venture Partners's portfolio value fell 20% quarter-over-quarter to $162M.

Based on Worth Venture Partners's 13F filing for Q1 2020, filed 15 May 2020.